Pharmacology of Kratom: An emerging botanical agent with stimulant, analgesic and opioid-like effects

Journal of the American Osteopathic Association

Volumn 112, Issue 12, 2012, Pages 792-799

  Prozialeck, Walter C ^a   Jivan, Jateen K ^a   Andurkar, Shridhar V ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLANT MEDICINAL PRODUCT;

ANALGESIA; CHEMISTRY; HUMAN; METHODOLOGY; MITRAGYNA; PHYTOTHERAPY; REVIEW; WITHDRAWAL SYNDROME;

HUMANS; MITRAGYNA; PAIN MANAGEMENT; PHYTOTHERAPY; PLANT PREPARATIONS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84870879775     PISSN: 00986151     EISSN: 19451997     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008(12):1-23.
2. Denneky C, Tsouraunis C. Dietary supplements and herbal medications. In: Katzung B, Masters S, Trevor A. Basic and Clinical Pharmacology. 12th ed. New York, NY: McGraw Hill; 2011:1125-1137.
3. American Osteopathic Association. Tenets of osteopathic medicine. American Osteopathic Association Web site. http://www.osteopathic.org/inside-aoa/about/leadership/Pages/tenets-of-osteopathic-medicine.aspx. Accessed August 22, 2012.
4. US Drug Enforcement Administration. Special intelligence brief: kratom (Mitragyna speciosa). Microgram Bulletin. 2006;39(3):30-32. http://www.justice.gov/dea/pr/micrograms/2006/mg0306.pdf. Accessed November 12, 2012.
5. Grewal KS. Observations on the pharmacology of mitragynine. J Pharmacol Exp Ther. 1932;46:251-271.
6. Jansen KL, Prast CJ. Ethnopharmacology of kratom and the Mitragyna alkaloids. J Ethnopharmacol. 1988;23(1)115-119.
7. León F, Habib E, Adkins JE, Furr EB, McCurdy CR, Cutler SJ. Phytochemical characterization of the leaves of Mitragyna speciosa grown in U.S.A. Nat Prod Commun. 2009;4(7):907-910.
8. Maruyama T, Kawamura M, Kikura-Hanajiri R, Takayama H, Goda Y. The botanical origin of kratom (Mitragyna speciosa; Rubiaceae) available as abused drugs in the Japanese markets. J Nat Med. 2009;63(3):340-344.
9. Suwanlert S. A study of kratom eaters in Thailand. Bull Narc. 1975;27(3):21-27.
10. Assanangkornchai S, Muekthong A, Sam-Angsri N, Pattanasattayawong U. The use of Mitragynine speciosa ("Krathom"), an addictive plant, in Thailand. Subst Use Misuse. 2007;42(14):2145-2157.
11. Jansen KL, Prast CJ. Psychoactive properties of mitragynine (kratom). J Psychoactive Drugs. 1988;20(4):455-457.
12. Shellard EJ. Ethnopharmacology of kratom and the Mitragyna alkaloids. J Ethnopharmacol. 1989;25(1):123-124.
13. Pichainarong N, Chaveepojnkamjorn W, Khobjit P, Veerachai V, Sujirarat D. Energy drinks consumption in male construction workers, Chonburi province. J Med Assoc Thai. 2004;87(12):1454-1458.
14. Vicknasingam B, Narayanan S, Beng GT, Mansor SM. The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. Int J Drug Policy. 2010;21(4):283-288.
15. Kapp FG, Maurer HH, Auwärter V, Winkelmann M, Hermanns-Clausen M. Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa). J Med Toxicol. 2011;7(3):227-231.
16. Kronstrand R, Roman M, Thelander G, Eriksson A. Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton. J Anal Toxicol. 2011;35(4):242-247.
17. Nelsen JL, Lapoint J, Hodgman MJ, Aldous KM. Seizure and coma following Kratom (Mitragynina speciosa Korth) exposure. J Med Toxicol. 2010;6(4):424-426.
18. Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow. and back again? a review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol. 2012;8(1):15-32.
19. Sheleg SV, Collins GB. A coincidence of addiction to "Kratom" and severe primary hypothyroidism. J Addict Med. 2011;5(4):300-301.
20. Krauth D. Substance called "Kratom" becoming a growing problem. The Palm Beach Post. July 1, 2011. http://www.palmbeachpost.com/health/substance-calledkratom-becoming-a-growing-problem-1575630.html. Accessed February 25, 2012.
21. Osterhaus H. Natural herb flavors students' day. The University Daily Kansan. January 23, 2008. http://kansan.com/archives/2008/01/23/osterhaus-natural-herbflavors-students-day/. Accessed February 25, 2012.
22. Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction. 2008; 103(6):1048-1050.
23. Schmidt MM, Sharma A, Schifano F, Feinmann C. "Legal highs" on the net-evaluation of UK-based websites, products and product information. Forensic Sci Int. 2011;206(1-3):92-97.
24. Kratom dosage. The Vaults of Erowid Web site. http://www.erowid.org/plants/kratom/kratom_dose.shtml. Accessed July 20, 2011.
25. The kratom user's guide. Sage Wisdom Web site. http://www.sagewisdom.org/kratomguide.html. Accessed July 20, 2011.
26. Kratom addiction?? [online forum]. WebMD Substance Abuse Community Web site. http://forums.webmd.com/3/substance-abuse-exchange/forum/350/32#32. Accessed July 20, 2011.
27. Ward J, Rosenbaum C, Hernon C, McCurdy CR, Boyer EW. Herbal medicines for the management of opioid addiction: safe and effective alternatives to conventional pharmacotherapy? CNS Drugs. 2011;25(12):999-1007. http://adisonline.com/cnsdrugs/Fulltext/2011/25120/Herbal_Medicines_for_the_Management_of_Opioid.2.aspx. Accessed February 29, 2012.
28. Controlled Substances Act, 21 USC §801 et seq.
29. US Department of Justice, Drug Enforcement Administration, Office of Diversion Control. Drugs and chemicals of concern: kratom (Mitragyna speciosa korth). Office of Diversion Control Web site. http://www.deadiversion.usdoj.gov/drugs_concern/kratom.htm. Accessed October 30, 2011.
30. Adkins JE, Boyer EW, McCurdy CR. Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity. Curr Top Med Chem. 2011;11(9):1165-1175.
31. Babu KM, McCurdy CR, Boyer EW. Opioid receptors and legal highs: Salvia divinorum and kratom. Clin Toxicol (Phila). 2008;46(2):146-152.
32. Matsumoto K, Horie S, Takayama H, et al. Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa. Life Sci. 2005;78(1):2-7.
33. Matsumoto K, Yamamoto LT, Watanabe K, et al. Inhibitory effect of mitra-gynine, an analgesic alkaloid from Thai herbal medicine, on neurogenic contraction of the vas deferens. Life Sci. 2005;78(2):187-194.
34. Matsumoto K, Hatori Y, Murayama T, et al. Involvement of μ-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxy-mitragynine, isolated from Thai herbal medicine Mitragyna speciosa. Eur J Pharmacol. 2006;549(1-3):63-70.
35. Macko E, Weisbach JA, Douglas B. Some observations on the pharmacology of mitragynine. Arch Int Pharmacodyn Ther. 1972;198(1):145-161.
36. Maurer HH. Chemistry, pharmacology, and metabolism of emerging drugs of abuse. Ther Drug Monit. 2010;32(5):544-549.
37. Sabetghadam A, Ramanathan S, Mansor SM. The evaluation of antinociceptive activity of alkaloid, methanolic, and aqueous extracts of Malaysian Mitragyna speciosa Korth leaves in rats. Pharmacognosy Res. 2010;2(3):181-185.
38. Shaik Mossadeq WM, Sulaiman MR, Tengku Mohamad TA, et al. Anti-inflammatory and antinociceptive effects of Mitragyna speciosa Korth methanolic extract. Med Princ Pract. 2009;18(5):378-384.
39. Takayama H, Ishikawa H, Kurihara M, et al. Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands. J Med Chem. 2002;45(9): 1949-1956.
40. Takayama H. Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa. Chem Pharm Bull (Tokyo). 2004;52(8):916-928.
41. Thongpradichote S, Matsumoto K, Tohda M, et al. Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitra-gynine in mice. Life Sci. 1998;62(16):1371-1378.
42. Utar Z, Majid MI, Adenan MI, Jamil MF, Lan TM. Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E2 production induced by lipopolysaccharide in RAW264.7 macrophage cells. J Ethnopharmacol. 2011;136(1):75-82.
43. Matsumoto K, Mizowaki M, Suchitra T, et al. Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems. Eur J Pharmacol. 1996;317(1):75-81.
44. Horie S, Koyama F, Takayama H, et al. Indole alkaloids of a Thai medicinal herb, Mitragyna speciosa, that has opioid agonistic effect in guinea-pig ileum. Planta Med. 2005;71(3):231-236.
45. Roche KM, Hart K, Sangali B, Lefberg J, Bayer M. Kratom: a case of a legal high. Clin Tox. 2008;46(7):598. Abstract 41.
46. McWhirter L, Morris S. A case report of inpatient detoxification after kratom (Mitragyna speciosa) dependence. Eur Addict Res. 2010;16(4):229-231.
47. Arndt T, Claussen U, Güssregen B, et al. Kratom alkaloids and O-desmethyltramadol in urine of a "Krypton" herbal mixture consumer. Forensic Sci Int. 2011;208(1-3):47-52.
48. Holler JM, Vorce SP, McDonough-Bender PC, Magluilo J Jr, Solomon CJ, Levine B. A drug toxicity death involving propylhexedrine and mitragynine. J Anal Toxicol. 2011;35(1):54-59. http://jat.oxfordjournals.org/content/35/1/54.long. Accessed October 29, 2012.
49. Philipp AA, Meyer MR, Wissenbach DK, et al. Monitoring of kratom or Krypton intake in urine using GC-MS in clinical and forensic toxicology. Anal Bioanal Chem. 2011;400(1):127-135.